NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
1.730
+0.030 (1.76%)
At close: Mar 9, 2026, 4:00 PM EDT
1.740
+0.010 (0.58%)
After-hours: Mar 9, 2026, 7:46 PM EDT
NRx Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -38.06 | -25.13 | -30.15 | -39.75 | -93.06 | -51.78 | |
| Depreciation & Amortization | 0.04 | 0.01 | 0.01 | 0 | 0 | 0 | |
| Other Amortization | 0.73 | 0.9 | - | - | - | 0.02 | |
| Stock-Based Compensation | 0.79 | 0.52 | 0.39 | 3.63 | 7.79 | 0.73 | |
| Other Operating Activities | 24.04 | 7.77 | 2.94 | -4.33 | 52.47 | 45.31 | |
| Change in Accounts Receivable | 0.01 | - | - | - | 0.83 | -0.83 | |
| Change in Accounts Payable | -10.07 | -5.22 | 2.66 | -1.61 | -0.02 | 1.18 | |
| Change in Other Net Operating Assets | 10.02 | 10.51 | 2.51 | 2.31 | -5.71 | 3.1 | |
| Operating Cash Flow | -12.5 | -10.64 | -21.66 | -39.76 | -37.7 | -2.27 | |
| Capital Expenditures | - | - | -0 | -0.01 | -0.01 | -0 | |
| Investing Cash Flow | -2.56 | - | -0 | -0.01 | -0.01 | -0 | |
| Short-Term Debt Issued | - | 1.05 | 0.94 | - | - | - | |
| Long-Term Debt Issued | - | 6.03 | - | 10.02 | - | 0.62 | |
| Total Debt Issued | 9.37 | 7.08 | 0.94 | 10.02 | - | 0.62 | |
| Short-Term Debt Repaid | - | -0.73 | -0.94 | - | -0.18 | - | |
| Long-Term Debt Repaid | - | -7.85 | -3.09 | -0.52 | -1.1 | - | |
| Total Debt Repaid | -4.17 | -8.58 | -4.04 | -0.52 | -1.28 | - | |
| Net Debt Issued (Repaid) | 5.2 | -1.5 | -3.09 | 9.5 | -1.28 | 0.62 | |
| Issuance of Common Stock | 9.47 | 5.91 | 8.12 | 22.71 | 53.68 | 2.58 | |
| Other Financing Activities | 5.93 | 3.07 | - | - | 11.05 | - | |
| Financing Cash Flow | 20.6 | 7.49 | 6.2 | 32.21 | 63.46 | 3.25 | |
| Net Cash Flow | 5.54 | -3.15 | -15.46 | -7.55 | 25.75 | 0.98 | |
| Free Cash Flow | -12.5 | -10.64 | -21.66 | -39.77 | -37.71 | -2.27 | |
| Free Cash Flow Per Share | -0.73 | -1.00 | -2.86 | -6.05 | -8.04 | -0.66 | |
| Cash Interest Paid | 0.37 | 0.37 | 0.89 | - | - | - | |
| Levered Free Cash Flow | 2.99 | 0.13 | -11.47 | -28.24 | -89.8 | 36.12 | |
| Unlevered Free Cash Flow | 2.26 | -0.63 | -11.4 | -28.24 | -89.79 | 36.14 | |
| Change in Working Capital | -0.04 | 5.29 | 5.16 | 0.7 | -4.9 | 3.45 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.